1. Home
  2. STN vs RGEN Comparison

STN vs RGEN Comparison

Compare STN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STN
  • RGEN
  • Stock Information
  • Founded
  • STN 1954
  • RGEN 1981
  • Country
  • STN Canada
  • RGEN United States
  • Employees
  • STN N/A
  • RGEN N/A
  • Industry
  • STN Military/Government/Technical
  • RGEN Medical/Dental Instruments
  • Sector
  • STN Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • STN Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • STN 9.3B
  • RGEN 8.2B
  • IPO Year
  • STN N/A
  • RGEN N/A
  • Fundamental
  • Price
  • STN $77.73
  • RGEN $141.78
  • Analyst Decision
  • STN Strong Buy
  • RGEN Buy
  • Analyst Count
  • STN 2
  • RGEN 10
  • Target Price
  • STN $105.00
  • RGEN $188.38
  • AVG Volume (30 Days)
  • STN 136.4K
  • RGEN 934.6K
  • Earning Date
  • STN 11-07-2024
  • RGEN 10-29-2024
  • Dividend Yield
  • STN 0.79%
  • RGEN N/A
  • EPS Growth
  • STN 14.50
  • RGEN N/A
  • EPS
  • STN 2.22
  • RGEN N/A
  • Revenue
  • STN $3,961,860,228.00
  • RGEN $602,354,000.00
  • Revenue This Year
  • STN $16.06
  • RGEN $0.08
  • Revenue Next Year
  • STN $9.44
  • RGEN $12.97
  • P/E Ratio
  • STN $35.31
  • RGEN N/A
  • Revenue Growth
  • STN 13.02
  • RGEN N/A
  • 52 Week Low
  • STN $59.55
  • RGEN $110.45
  • 52 Week High
  • STN $88.42
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • STN 36.69
  • RGEN 43.50
  • Support Level
  • STN $76.03
  • RGEN $138.80
  • Resistance Level
  • STN $85.40
  • RGEN $150.72
  • Average True Range (ATR)
  • STN 1.33
  • RGEN 4.98
  • MACD
  • STN -0.36
  • RGEN -0.92
  • Stochastic Oscillator
  • STN 25.54
  • RGEN 24.50

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. The company is geographically diversified in three regional operating units namely Canada, United States and Global, offering similar services across all regions. The company offers services in various sectors across the project life cycle through five business operating units infrastructure, water, buildings, environmental services, and energy and resources. The company provides professional services in all phases of the project life cycle: planning, design, construction administration, commissioning, maintenance, decommissioning, and remediation.

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

Share on Social Networks: